Toxicity and response criteria of the Eastern Cooperative Oncology Group
Explore this paper's citation graph
Summary
The Eastern Cooperative Oncology Group criteria for toxicity and response are presented to facilitate future reference and to encourage further standardization among those conducting clinical trials.
- Type
- article
- Published
- 1982-12-01
- Cited by
- 11,511
- References
- 0
- OpenAlex
- https://openalex.org/W2076668534
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2261448
Keywords
Medicine, Toxicity, Standardization, Oncology, Clinical trial
References
No references recorded for this paper.
Cited by
- Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer
- Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancer.
- Serum tumor markers may precede instrumental response to chemotherapy in patients with metastatic cancer.
- Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women.
- A New Tool to Assess Family Caregivers’ Burden during End-of-Life Care
- Das Urothelkarzinom des oberen Harntraktes
- Ziconotide adverse events in patients with cancer pain: a multicenter observational study of a slow titration, multidrug protocol.
- An Intra-Patient Dose-Escalation Study of Disodium Pamidronate plus Radiotherapy versus Radiotherapy Alone for the Treatment of Osteolytic Metastases
- A dose intensive regimen of cytosine arabinoside and daunorubicin for chronic myelogenous leukemia in blast crisis.
- Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
- Pilot trial of cisplatin, radiation, and WR2721 in carcinoma of the uterine cervix: a New York Gynecologic Oncology Group study.
- Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death.
- Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin.
- ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies.
- Phase I study of paclitaxel (taxol) and granulocyte colony stimulating factor (G-CSF) in patients with unresectable malignancy
- Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan.
- Glutathione‐associated enzymes in head and neck squamous cell carcinoma and response to cisplatin‐based neoadjuvant chemotherapy
- Phase I Study of Gemcitabine and Liposomal Doxorubicin in Relapsed Ovarian Cancer
- The application of computer touch-screen technology in screening for psychosocial distress in an ambulatory oncology setting.
- Imatinib Mesylate
Related papers
- Standardization for Wood-based Panels in China
- Current Oncology: A Multidisciplinary Medium for Clinical Oncology
- Future Approaches to Precision Oncology–Based Clinical Trials
- American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.
- Cancer Research, Tumor Markers, Clinical Oncology
- Immuno-Oncology's ACE in the Hole